U.S. FDA Grants BirchBioMed Orphan Drug Designation for FS2 in the Treatment of Idiopathic Pulmonary Fibrosis

BirchBioMed _ FDA Grants FS2 ODD for IPF_News Release_FINAL 02-12-2025